Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

Treatment burden is important to patients but often overlooked by clinicians

Claudia C. Dobler
Breathe 2021 17: 210031; DOI: 10.1183/20734735.0031-2021
Claudia C. Dobler
1The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia
2Dept of Respiratory and Sleep Medicine, Liverpool Hospital, Sydney, NSW, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Claudia C. Dobler
  • For correspondence: c.dobler@unsw.edu.au
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The latest issue of Breathe focuses on “treatment burden” and the effects of this workload on patients: read the introductory editorial by Chief Editor @ClaudiaCDobler https://bit.ly/3djgNeO

The focus of this issue of Breathe is “treatment burden”, which is the work that patients must do to implement medical treatments, for example, taking medications, going to medical appointments, making lifestyle changes (diet, exercise, smoking cessation, etc.) and the effect of this workload on patient functioning and wellbeing [1]. The treatment workload associated with managing a respiratory condition can be substantial [2–6]. Treatment burden is distinct from “disease burden”, which describes the morbidity and mortality associated with a disease. In this issue of Breathe we hear from patients with different respiratory conditions [7–9] as well as from carers [10] about the challenges associated with their healthcare workload. Their accounts highlight the importance of healthcare professionals working together with patients and carers to reduce treatment burden.

If the treatment workload goes beyond a patient's capacity, nonadherence to treatment is often the consequence. Causes can be a lack of patient understanding, for example due to treatment complexity or a patient's cognitive impairment, forgetfulness, difficulties in accessing the prescribed treatment due to cost or need to travel to a pharmacy, or practical issues such as difficulties opening medicine bottles or swallowing pills. Traditionally, clinicians have focused on increasing capacity in this situation, mainly through education. While it is important to provide patients with information that they can understand, adjusting for health literacy and using language interpreters if indicated, sometimes a reduction of treatment burden, for example through de-prescribing of medications, may be the most appropriate course of action for an individual patient. In the article “Discussing treatment burden” the authors give helpful tips on how to consider and discuss aspects of treatment burden in the patient–clinician encounter [11].

Considerations about treatment burden are ideally integrated into a shared decision-making process between clinician and patient/carer, in which the advantages and disadvantages of a treatment are weighed against each other [12]. Unfortunately, clinicians usually do not quantify the potential benefit of a treatment when talking to patients, for example by pointing out how many persons out of 100 treated persons will experience a specific positive outcome, or the average improvement than can be expected with treatment. Instead, clinicians frequently make vague statements such as “this inhaler will reduce the risk of flare ups”. A major reason for this is probably that most clinicians do not memorise information on quantitative treatment benefits. Decision aids with written information for use during the clinical encounter can overcome this barrier. Quantitative information on treatment benefits will enable patients to make informed decisions about whether they are willing to accept therapies with a substantial treatment burden.

The article on “Treatment burden and ability to work” in this issue explores how the healthcare system, the workplace and the state can support working age people with chronic health conditions or disabilities to remain employed [13].

I would like to thank the European Lung Foundation for making a major contribution to this issue of Breathe by working closely together with patients and carers on a number of articles.

The following quote originated in the context of design thinking and customer experience, but is also relevant to a patient-centred healthcare approach that includes considerations of treatment burden:

We spend a lot time designing the bridge, but not enough time thinking about the people who are crossing it.

Dr. Prabhjot Singh

Footnotes

  • Conflict of interest: C.C. Dobler has nothing to disclose.

  • Received February 14, 2021.
  • Accepted February 15, 2021.
  • Copyright ©ERS 2021
http://creativecommons.org/licenses/by-nc/4.0/

Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Eton DT,
    2. Ramalho de Oliveira D,
    3. Egginton JS, et al.
    Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study. Patient Relat Outcome Meas 2012; 3: 39–49. doi:10.2147/PROM.S34681
    OpenUrlCrossRefPubMed
  2. ↵
    1. Sawicki GS,
    2. Sellers DE,
    3. Robinson WM
    . High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros 2009; 8: 91–96. doi:10.1016/j.jcf.2008.09.007
    OpenUrlCrossRefPubMed
    1. Harb N,
    2. Foster JM,
    3. Dobler CC
    . Patient-perceived treatment burden of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2017; 12: 1641–1652. doi:10.2147/COPD.S130353
    OpenUrlCrossRefPubMed
    1. Spurr L
    . The treatment burden of long-term home noninvasive ventilation. Breathe 2021; 17: 200291. doi:10.1183/20734735.0291-2020
    OpenUrlAbstract/FREE Full Text
    1. Ting NCH,
    2. El-Turk N,
    3. Chou MSH, et al.
    Patient-perceived treatment burden of tuberculosis treatment. PLoS One 2020; 15: e0241124.
    OpenUrl
  3. ↵
    1. El-Turk N,
    2. Chou MSH,
    3. Ting NCH, et al.
    Treatment burden experienced by patients with lung cancer. PLoS One 2021; 16: e0245492. doi:10.1371/journal.pone.0245492
    OpenUrl
  4. ↵
    1. Maetz J,
    2. Denning J
    . The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis. Breathe 2021; 17: 210013. doi:10.1183/20734735.0013-2021
    OpenUrlAbstract/FREE Full Text
    1. Williams C,
    2. Flewett R,
    3. Salgueiro B
    . Lung transplantation: the patient view from either side of the operating table. Breathe 2021; 17: 200305. doi:10.1183/20734735.0305-2020
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Wilkens M,
    2. Bartlett M,
    3. Willersinn F, et al.
    The patient perspective of alpha-1 antitrypsin deficiency: disease burden and unmet needs. Breathe 2021; 17: 200340. doi:10.1183/20734735.0340-2020
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Denning J,
    2. Carter P,
    3. Galvin L, et al.
    How treatment burden affects the carer: the experiences of three individuals, a mother, a daughter and a husband. Breathe 2021; 17: 200327. doi:10.1183/20734735.0327-2020
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Powell P,
    2. Saggu R,
    3. Jones S, et al.
    Discussing treatment burden. Breathe 2021; 17: 200284. doi:10.1183/20734735.0284-2020
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Dobler CC,
    2. Harb N,
    3. Maguire CA, et al.
    Treatment burden should be included in clinical practice guidelines. BMJ 2018; 363: k4065. doi:10.1136/bmj.k4065
    OpenUrlFREE Full Text
  9. ↵
    1. Trakoli A
    . Treatment burden and ability to work. Breathe 2021; 17: 210004. doi:10.1183/20734735.0004-2021
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Vol 17 Issue 1 Table of Contents
Breathe: 17 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Treatment burden is important to patients but often overlooked by clinicians
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Treatment burden is important to patients but often overlooked by clinicians
Claudia C. Dobler
Breathe Mar 2021, 17 (1) 210031; DOI: 10.1183/20734735.0031-2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Treatment burden is important to patients but often overlooked by clinicians
Claudia C. Dobler
Breathe Mar 2021, 17 (1) 210031; DOI: 10.1183/20734735.0031-2021
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Pulmonary vascular disease for the general respiratory clinician
  • Sleep medicine in Europe: 50 years of evolution
  • Managing respiratory disease in pregnancy
Show more Editorials

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society